Skandinaviska Enskilda Banken AB (publ) - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 247 filers reported holding ACCELERON PHARMA INC in Q2 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$11,275,000
-2.9%
65,516
-29.2%
0.06%
-12.7%
Q2 2021$11,606,000
+498.2%
92,487
+546.4%
0.07%
+446.2%
Q1 2021$1,940,000
+50.2%
14,307
+41.7%
0.01%
+44.4%
Q4 2020$1,292,000
+112.5%
10,100
+87.0%
0.01%
+125.0%
Q3 2020$608,000
-42.5%
5,400
-51.4%
0.00%
-55.6%
Q2 2020$1,057,00011,1000.01%
Other shareholders
ACCELERON PHARMA INC shareholders Q2 2020
NameSharesValueWeighting ↓
Novo Holdings A/S 1,103,937$53,563,0005.39%
GREAT POINT PARTNERS LLC 758,000$36,778,0005.10%
Foresite Capital Management II, LLC 244,756$11,876,0004.18%
GREAT POINT PARTNERS LLC 552,300$26,798,0003.71%
Foresite Capital Management III, LLC 278,753$13,525,0002.91%
QVT Financial LP 190,977$9,266,0002.66%
Perceptive Advisors 1,528,205$74,149,0001.94%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,126,800$54,672,0001.92%
SECTORAL ASSET MANAGEMENT INC 306,626$14,877,0001.66%
Parametrica Management Ltd 5,645$274,0001.30%
View complete list of ACCELERON PHARMA INC shareholders